explore -WSS

explore

author：Wikipedia 2025-10-01 00:07:07 - browse：78351

A gene-edited Yucatan minipig. -- health coverage from STAT — A gene-edited Yucatan minipig created by eGenesis. Courtesy Liz Linder/eGenesis

For three days in December, an ICU room at the Hospital of the University of Pennsylvania bore witness to the first-ever merging of two powerful new technologies poised to change the future of transplant medicine.

On a gurney, a brain-dead patient lay connected to a whirring Rube Goldberg-esque machine: a tangle of tubes and siphons on wheels. From a cannula on one end, blood from the patient entered, was pumped full of oxygen and other nutrients, then pushed into a cozy, temperature-controlled chamber containing a liver — one that until very recently had belonged to a CRISPR-edited pig — before being returned to the patient.

The experiment, designed to test whether a genetically engineered porcine liver kept alive in a box could support the circulatory system of a human, was a resounding success, the research team said Thursday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： For Medicare Advantage, Democrats want stronger protections around AI

hotspot

leisure time

WSS

The Readout: Gilead, Bernie Sanders, and other pharma news

To avoid data mishandling cases, universities eye AI and other tools

Key House Republican on health care plans exit from Congress

How digital tools helped lower hypertension in marginalized patients

Use doctors trained outside the U.S. to ease the physician shortage

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

focus

explore

hotspot

Activists slam private health insurers over coverage restrictions

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Hepatitis C has a cure — but many Americans still lack access to it

What we’ve learned from the Aduhelm mess

Psychedelics group wrestles with new pharma identity

'Screen and refer' systems are hurting patients

DIEP, the 'gold standard' of breast reconstruction, is under threat

Drug cartel violence flares in western Mexico after vigilante leader's killing

After affirmative action ruling, medical educators look to 'holistic review'

Skip the lead apron during X

focus

A disappointing year of Humira biosimilars

Security flaws in third

The biotech scorecard for Q3: 15 stock

STAT wants to know your pick for a great summer read or listen

Use doctors trained outside the U.S. to ease the physician shortage

The dental labor crisis is a moment of opportunity

entertainment

hotspot

leisure time

explore